IQVIA (IQV) is a publicly traded Healthcare sector company. As of October 3, 2026, IQV trades at $257.79 with a market cap of $42.91B and a P/E ratio of 32.65. IQV moved -0.96% today. Year to date, IQV is +14.57%; over the trailing twelve months it is +26.36%. Its 52-week range spans $134.65 to $277.40. Analyst consensus is strong buy with an average price target of $275.57. Rallies surfaces IQV's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for IQV combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $257.79 |
| Market Cap | $42.91B |
| P/E Ratio | 32.65 |
| EPS | $7.91 |
| Dividend Yield | 0.00% |
| 52-Week High | $277.40 |
| 52-Week Low | $134.65 |
| Volume | 1.03M |
| Avg Volume | 0 |
| Revenue (TTM) | $16.31B |
| Net Income | $1.36B |
| Gross Margin | 0.00% |
15 analysts cover IQV: 0 strong buy, 14 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $275.57.